Long-term surveillance of bladder tumours: Current practice in the United Kingdom and Ireland

European Urology

Volumn 43, Issue 5, 2003, Pages 485-488

  Wazait, H D ^a   Al Bhueissi, S Z ^a   Patel, H R H ^a   Nathan, M S ^a   Miller, R A ^a  

^a WHITTINGTON HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Bladder cancer; Follow up; Surveillance

Indexed keywords

ARTICLE; BLADDER TUMOR; CANCER EPIDEMIOLOGY; CANCER SURVIVAL; CYSTOSCOPY; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; IRELAND; MEDICAL PRACTICE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; TRANSITIONAL CELL CARCINOMA; UNITED KINGDOM; URINE CYTOLOGY;

CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; DATA COLLECTION; GREAT BRITAIN; HUMANS; IRELAND; NEOPLASM RECURRENCE, LOCAL; URINARY BLADDER NEOPLASMS; URINE; UROLOGY;

EID: 0038304566     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(03)00052-6     Document Type: Article

References (17)

1. Quinn M, Babb P, Brock A, Kirby L, Jones J. Cancer trends in England and Wales 1950-1999. Off Natl Stat 2001);66:1-27.
2. Bailey M, Sarosdy M. Fast facts-bladder cancer. Health Press Ltd.; 2000. p. 1-10.
3. Abel PD. Follow-up of patients with "superficial" transitional cell carcinoma of the bladder: the case for a change in policy. Br J Urol 1993;72(2):135-42.
4. Wright MPJ, Jones DJ. Surveillance for bladder cancer: the management of 4.8 million people. BJU Int 2000;85:431-3.
5. Fujii Y, Fukui I, Kihara K, Tsujii T, Kageyama Y, Oshima H. Late recurrence and progression after a long tumour-free period in primary Ta and T1 bladder cancer. Eur Urol 1999;36(4):309-13.
6. Leblanc B, Duclos AJ, Benard F, Cote J, Valiquette L, Paquin JM, et al. Long-term follow-up of initial Ta grade 1 transitional cell carcinoma of the bladder. J Urol 1999;162(6):1946-50.
7. Morris SB, Gordon EM, Shearer RJ, Woodhouse CR. Superficial bladder cancer: for how long should a tumour-free patient have check cystoscopies? Br J Urol 1995;75(2):193-6.
8. England HR, Paris AM, Blandy JP. The correlation of T1 bladder tumour history with prognosis and follow-up requirements. Br J Urol 1981;53(6):593-7.
9. Haukaas S, Daehlin L, Maartmann-Moe H, Ulvik NM. The long-term outcome in patients with superficial transitional cell carcinoma of the bladder: a single-institutional experience. BJU Int 1999;83(9):957-63.
10. Holmang S, Hedelin H, Anderstrom C, Johansson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995;153(6):1823-6.
11. Zieger K, Wolf H, Olsen PR, Hojgaard K. Long-term follow-up of non-invasive bladder tumours (stage Ta): recurrence and progression. BJU Int 2000;85(7):824-8.
12. Greene LF, Hanash KA, Farrow GM. Benign papilloma or papillary carcinoma of the bladder? J Urol 1973;110(2):205-7.
13. Parmar MK, Freedman LS, Hargreave TB, Tolley DA. Prognostic factors for recurrence and follow-up policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J Urol 1989;142:284-8.
14. Morgan JDT, Bowsher W, Griffiths DFR, Mathews PN. Rationalisation of follow-up in patients with non-invasive bladder tumours. Br J Urol 1991;67:158-61.
15. Mufti GR, Virdi Js, Singh M. Solitary Ta-T1 G1 bladder tumour-history and long-term prognosis. Eur Urol 1990;18:101-6.
16. Thompson RA, Campbell EW, Kramer HC, Jacobs SC, Naslund MJ. Late invasive recurrence despite long-term surveillance for superficial bladder cancer. J Urol 1993;149:1010-1.
17. Rife CC, Farrow GM, Utz DC. Urine cytology of transitional cell neoplasms. Urol Clin North Am 1979;6(3):599-612.